NEW YORK (GenomeWeb News) – GeneNews today said that it recorded C$37,000 (US$33,000) in revenues for the fourth quarter, down 38 percent year over year from C$60,000 a year ago.

For the three months ended Dec. 31, 2013 the company recorded C$36,744 in revenues derived from milestone revenues from the completion of a research project undertaken at the start of the year, compared to no such revenues recorded in the year-ago period, GeneNews said in a document filed with Canadian regulators.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.